Amyotrophic Lateral Sclerosis: A Focus on Disease Progression

Abstract

Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerative disease in which motor neuron death is induced, a wide range of biomarkers have been selected to identify therapeutic targets. ALS shares altered molecular pathways with other neurodegenerative diseases, such as Alzheimer's, Huntington's, and Parkinson's… (More)
DOI: 10.1155/2014/925101

Topics

4 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics